dr. michaelis on fedratinib in myelofibrosis treatment
Published 4 years ago • 308 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:30
dr. michaelis on unanswered questions in myelofibrosis treatment
-
1:42
dr. mesa on ruxolitinib vs fedratinib in myelofibrosis treatment
-
1:12
dr. kuykendall on the approval of fedratinib in myelofibrosis
-
7:43
the role of fedratinib in myelofibrosis
-
0:57
dr. mesa on challenges in myelofibrosis treatment
-
1:24
dr. mesa on current data with ruxolitinib and fedratinib in myelofibrosis
-
1:00
dr. mesa on the utility of ruxolitinib versus fedratinib in myelofibrosis
-
1:12
dr. mesa on the differences between fedratinib and ruxolitinib in myelofibrosis
-
1:16
dr. mesa on the fda approval of fedratinib in myelofibrosis
-
1:27
dr. kuykendall on choosing ruxolitinib or fedratinib in myelofibrosis
-
0:50
dr. snyder on how ruxolitinib and fedratinib may pave the way to transplant in myelofibrosis
-
4:46
fedratinib for primary myelofibrosis
-
2:13
dr. mesa on the efficacy of fedratinib in patients with myelofibrosis and low platelet counts
-
1:48
dr. scherber on the treatment of myelofibrosis
-
1:11
dr. mesa on the utility of fedratinib for patients with myelofibrosis who progress on ruxolitinib
-
2:26
dr. dunavin on treatment considerations in myelofibrosis
-
38:10
a treatment option in myelofibrosis
-
1:02
dr. kremyanskaya on unmet needs in myelofibrosis
-
1:29
evaluating the next steps for research in myelofibrosis